ASH's Shares Rally 30% in 6 Months: What's Driving the Upside?

Ashland's shares have gained 30.2% in six months as cost cuts, portfolio optimization and a $1-billion buyback support returns.

Zacks Investment Research • Sep 29, 2026

Ashland scales Transformed Vegetable Oils technology platform in crop care, launches agrimer™ eco-disperse OD polymeric dispersant

WILMINGTON, Del., Sept. 22, 2026 (GLOBE NEWSWIRE) -- Continuing to scale its Transformed Vegetable Oils (TVO™) technology platform, Ashland Inc. (NYSE: ASH), today announced the global launch of agrimer™ eco-disperse OD TVO™ polymeric dispersant, a patented, nature-based dispersant developed for non-aqueous crop protection formulations.

GlobeNewsWire • Sep 22, 2026

Ashland Inc. (ASH) Analyst/Investor Day Transcript

Ashland Inc. (ASH) Analyst/Investor Day Transcript

Seeking Alpha • Sep 18, 2026

Here's Why You Should Retain ASH Stock in Your Portfolio Now

Ashland is using cost savings, portfolio optimization and buybacks to strengthen margins and free cash flow despite tariff and demand headwinds.

Zacks Investment Research • Sep 16, 2026

Ashland Innovation Day to be held September 17, 2026

Wilmington, Del., Sept. 14, 2026 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) will host an Innovation Day webcast on September 17, 2026.

GlobeNewsWire • Sep 14, 2026

Ashland to host Innovation Day for analysts and investors

Wilmington, Del., Aug. 31, 2026 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) will host a live Innovation Day webcast for analysts and investors from Wilmington, Delaware on September 17, 2026. The event will provide an updated view of Ashland's Technology Platforms, including their commercial progress and scalability.  Registration is required and can be accessed from the following link: innovationday26.ashland.com

GlobeNewsWire • Aug 31, 2026

Ashland (ASH) Up 2% Since Last Earnings Report: Can It Continue?

Ashland (ASH) reported earnings 30 days ago. What's next for the stock?

Zacks Investment Research • Aug 27, 2026

ASH Launches Permexa Sodium Caprate to Support Oral Biologics Growth

Ashland launches Permexa sodium caprate to support oral peptide and biologic development with enhanced processing and permeability.

Zacks Investment Research • Aug 25, 2026

Ashland advances high-growth oral biologics delivery applications with launch of permexa™ sodium caprate

WILMINGTON, Del., Aug. 24, 2026 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH), is announcing the launch of permexa™ sodium caprate, a high-performance intestinal permeation enhancer designed to support the scalable development and commercialization of oral peptide, biologic and low-permeability drug products, including rapidly expanding GLP-1 agonists and related therapeutic pipelines.

GlobeNewsWire • Aug 24, 2026

Ashland Inc.: Activist Pressure Starts To Pay Off

Ashland Inc. (ASH) remains a Buy, with the investment case now centered on activist-driven M&A potential and strategic alternatives. Life Sciences and Personal Care segments, comprising 82% of gross EBITDA, continue to deliver growth and margin stability, underpinning valuation. Multiple activist investors, including Standard Industries and Ancora, have driven board changes, capital allocation reviews, and engagement with potential acquirers.

Seeking Alpha • Aug 13, 2026